Propionic acidemia is an autosomal recessive disorder caused by a deficiency in the mitochondrial enzyme propionyl-CoA carboxylase (PCC). PCC is composed of two subunits, α and β, encoded by the PCCA and PCCB genes, respectively. We analyzed mutations of the PCCA gene using patients' fibroblasts diagnosed with α subunit deficiency. By RT-PCR, four of 12 cell lines examined appeared to have a larger transcript present at a level comparable with that of the expected normal species. Sequencing of the larger transcript revealed an 84 bp insertion at nt 1209 of the coding sequence. Its incorporation in the transcript results in translation termination due to the presence of two inframe stop codons. The 84 bp insertion was found to originate from the intron between nt 1209 and 1210. Consensus splice donor and acceptor sites were found at the 3′-and 5′-ends of the insertion, respectively. The insertion was also found in the remaining eight cell lines as well as in normal cells, but at a much reduced level compared with the normal length sequence. Mutation analysis of the four cell lines showing seemingly elevated levels of the insertion sequence revealed one nonsense mutation (R288X), two frameshift deletions (700del5 and 1115del4) and one splice mutation (1671IVS+5G→C) as expressed alleles. We conclude that the common characteristic of the four cell lines is that they contain mRNA destabilizing mutations that reduce the mRNA level of the normal length sequence. Consequently, the low levels of cryptic mRNAs become detectable at a level similar to that of the residual level of the normal length mRNA. We suggest that screening for an increased proportion of the 84 bp insertion by RT-PCR can be used as a rapid assay for RNA destabilizing mutations. Our results suggest caution in associating such mutations with aberrant mRNA species, such as cryptic splice products, which may instead be part of the 'background noise' of the splicing machinery.
INTRODUCTION
Propionic acidemia is a rare, autosomal recessive inborn error of the catabolism of branched chain amino acids, fatty acids with odd numbered chain lengths and other metabolites (1) . It is a clinically heterogeneous disease, with a severe ketoacidotic form which can be fatal in the neonatal period to a mild, later onset form which may be associated with episodic ketoacidosis (1) . It is caused by deficiency of propionyl-CoA carboxylase (PCC) (EC 6.4.3.1) activity, a biotin-dependent, mitochondrial enzyme that catalyzes the carboxylation of propionyl-CoA to D-methylmalonyl-CoA.
PCC is a heteropolymeric enzyme composed of α and β subunits in the proposed configuration α 4 β 4 or α 6 β 6 , with the α subunit containing the biotin prosthetic group. The α and β subunit cDNAs have been cloned and the PCCA (α subunit) and PCCB (β subunit) genes have been mapped to chromosomes 13q32 and 3q13.3-q22, respectively (2, 3) . The identity of the defective gene in patients with propionic acidemia can be determined by complementation studies in which patient cell lines are fused with tester cell lines of known complementation status and the resulting heteropolykaryons assayed for restoration of propionate metabolism (4) . These studies have revealed two principal complementation groups: pccA, corresponding to mutations of the PCCA α subunit gene, and pccBC and subgroups, corresponding to mutations of the PCCB β subunit gene. With identification of the defective gene, cell lines can be analyzed for mutation by conventional techniques. Several mutations have been identified in the PCCB gene (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) , while only recently mutations in the PCCA gene have begun to be described (15) .
In this study, we have examined cell lines of the pccA complementation group for mutations in the PCCA gene. During the course of the experiments, we noted that the RT-PCR product of one segment of the α subunit mRNA from normal cells consistently gave the expected product and a second, larger product at much lower level. Most mutant cell lines also gave the second RT-PCR product, but in several cases it was at a level similar to that of the normal length product as obtained by PCR. In this study, we report the origin and structure of the larger transcript and show that its prominence in patient cell lines is associated with mutations compatible with destabilization of the normal length transcript. 
RESULTS
The PCC α subunit cDNA was divided into six overlapping segments for amplification by RT-PCR (Table 1) . One of the segments, IIIA, gave two PCR products, one of the expected length and a faint, larger product as well. They were detected in a similar ratio in all normal cell lines examined as well as in eight out of 12 mutant cell lines (Fig. 1 , lanes C1-C4 show normal cell lines). However, the remaining four cell lines showed the larger PCR product at a level comparable with that of the normal length sequence. Using [ 35 S]dATP labeling of the PCR products, it was determined that the ratio of the larger to smaller product was 0.15 ± 0.05 for the four normal cell lines and 1.3 ± 0.22 for the four distinct patient cell lines. By sequence analysis, the larger PCR product was found to contain an 84 bp insertion between nt 1209 and 1210 of the coding sequence and was localized in genomic DNA within the intervening 4.5 kb intron ∼3.0 kb from nt 1209 (Fig. 2) . The region encompassing the 84 bp segment is structurally that of an exon with compatible 3′ acceptor and 5′ donor sites, although the reading frame is disrupted by two in-frame termination codons (Fig. 2, sequence) . Sequence analysis of the flanking donor and acceptor splice sites of the extra exon failed to reveal mutations in any of the four patient cell lines showing a relative increase in the aberrant transcript (data not shown). Nevertheless, for each of the cell lines other changes were detected in the RT-PCR products of other amplification segments. These changes and the corresponding mutations in genomic DNA are described in the following paragraphs. The mutations found in each cell line are summarized in Table 2 . DNA diagnostic tests for the mutations are shown in Figure 3 and Table 3 . The RNA species found for all cell lines are depicted in Figure 4 . f Refers to panels in Figure 3 . 
Cell line 117 (R.H.)
This cell line was previously shown to have absent PCC α mRNA and a normal level of PCC β mRNA by northern blot (16, 17) . Both the α and β subunits were absent in [ 35 S]methionine labeling experiments, the latter because the β subunit is unstable in the absence of α subunits (17, 18) . Using RT-PCR to detect trace mRNA, segment IIIA revealed the two PCR products in equal proportions, as described above ( Fig. 1 ). In addition, RT-PCR analysis of segment IIIB revealed a lower band corresponding to a 103 bp deletion near the 3′-end of the coding sequence at positions 1569-1671. No normal length PCR product was detected in segment IIIB. To determine if the insertion and the deletion were from the same allele, different PCRs with the same oligonucleotide 5′ of the 84 bp insertion and oligonucleotides at varying 3′ locations were carried out on the cDNA (Fig. 5) . Two species were detected with 3′ primers located before the 103 bp deletion ( In each case, one species was of normal size and the other contained the 84 bp insertion. However, when the 3′ primer was located in the 103 bp deletion, no normal length PCR product was detected (Fig. 5, 1563/1441 ). When the 3′ primer was located after the 103 bp deletion, two species were detected (Fig. 5 , 1563/1456). In this case, one species contained the 84 bp insertion and the 103 bp deletion while the other species contained only the 103 bp deletion. A schematic of the two species found is shown in Figure 4 (117). Analysis of genomic DNA showed the deleted sequence to be that of an exon with a G→C substitution at position +5 of the 5′ donor sequence following nt 1671 of the coding sequence ( made for this mutation showed the patient's DNA to be heterozygous ( Fig. 3A and Table 3 ). mRNA corresponding to the second allele was not detected by RT-PCR, suggesting that it is not expressed or is highly unstable. The second mutation remains to be identified.
Cell line 503 (P.M.)
As with cell line 117, this cell line was previously shown to have no PCC α mRNA by northern blotting (17) and undetectable α and β subunits of PCC (16) . By RT-PCR of segment IIIA, the normal length and 84 bp insertion species were detected at similar levels ( Fig. 1) . Analysis of fragment IIIB revealed the same 103 bp deletion found in cell line 117, though at a reduced level compared with normal, and, in contrast to cell line 117, a PCR product of normal length. Direct sequencing and the diagnostic test for the 1671IVS+5G→C mutation found in cell line 117 were negative (data not shown). When RT-PCR encompassing both segments IIIA and IIIB was done, three RNA species of different size could be detected (similar to species 1-3 found in cell line 3148 shown in Fig. 6 ). The first species contained the 84 bp insertion, the second species was of normal size and the third species contained the 103 bp deletion. In contrast to cell line 117, the 84 bp insertion was never found in the same mRNA as the 103 bp deletion. When cell line 503 was subjected to SSCP analysis of all RT-PCR segments, additional mobility shifts were found in segment II. Two mutations 5′ of the site of the 84 bp insertion were detected by direct sequencing of the PCR product: a 5 bp deletion, 700-704delCTAAT (700del5), and a nonsense mutation, 862C→T (R288X). Subclones spanning segments II, IIIA and IIIB showed the deletion and nonsense mutations to be on separate alleles and present in all three types of RT-PCR products described above. In all, six different mRNA species were detected, three with 700del5 and three with 862C→T (Fig. 4 , 503, and Table 2 ). For each mutation, one species had the 84 bp insertion, one had the 103 bp deletion and the third was of normal size. No mRNA species was identified that did not contain either 700del5 or 862C→T. DNA tests for each mutation revealed their heterozygosity ( Fig. 3B and C and Table 3 ).
Cell line 3148 (B.V.)
RT-PCR of segment IIIA of the residual mRNA showed equal intensity of the normal product and the one containing the 84 bp insertion (Figs 1 and 6 , species 1 and 2). RT-PCR of segments IIIA and IIIB also revealed the 103 bp deletion found in cell lines 117 and 503, although at a lower level than the normal length product (Fig. 6, species 3) . In addition, a smaller product was identified among the RT-PCR products of segment IIIA-IIIB containing a deletion spanning nt 991-1354, which includes four exons and the site of the 84 bp insertion (Fig. 4, 3148 , and Fig. 6 , species 4). The 1671IVS+5G→C mutation causing the exon skipping observed in cell line 117 was not present. SSCP analysis revealed a mobility shift in segment II. Direct sequencing of the segment revealed the 862C→T nonsense mutation observed in cell line 503 ( Table 2 ). The mutation was seemingly homozygous in genomic DNA, although hemizygosity at the PCCA gene could not be excluded (Fig. 3C and Table 3 ). All products except the minor species containing the 103 bp deletion were sequenced directly and found to contain the 862C→T nonsense mutation. As shown for cell line 503, the 84 bp insertion was never in the same mRNA species as the 103 bp deletion for this patient.
Cell line 3153 (M.Y.)
RT-PCR of segment IIIA gave approximately equal levels of the normal length and 84 bp insertion products (Fig. 1 ). As for cell line 503, three different RT-PCR products were produced when the PCR included segments IIIA and IIIB (Fig. 4 , 3153, similar to species 1-3 found in cell line 3148 shown in Fig. 6 ). One contained the 84 bp insertion, one was of normal size and the third contained the 103 bp deletion found in the other cell lines, the last at reduced level compared with the other two. Upon SSCP analysis of the cDNA, a 4 bp deletion, 1115-1118delAATG (1115del4), was identified without a normal sequence counterpart (Table 2 ). Direct sequencing of genomic DNA confirmed homozygosity of 1115del4. A DNA diagnostic test for the mutation produced, by mixing the patient's PCR product with control PCR product, a heteroduplex on electrophoresis, as expected ( Fig. 3D and Table 3 ). The parents are consanguineous (19) . Direct sequencing of the RT-PCR products encompassing the 4 bp deletion, the 84 bp insertion and the 103 bp deletion confirmed that all contained the 1115del4 mutation (Fig. 4, 3153) . As with cell lines 503 and 3148, cell line 3153 was negative for the 1671IVS+5G→C mutation (data not shown).
DISCUSSION
The prominence of the 84 bp insertion in mutant mRNA transcripts in four out of 12 pccA cell lines initially suggested the likelihood of a common mutation causing cryptic splicing. However, the presence of the same transcript at very low level in normal cell lines and the absence of mutations at either the candidate donor or acceptor splice junctions suggested instead that the cryptic exon was of natural, though trace level, origin. An alternatively spliced, functional exon was excluded, since this insertion contains two in-frame termination codons. This would give a polypeptide of 403 of the expected 703 amino acids and deficiency of part of the predicted biotin carboxylase function (20) and the biotin attachment site (21) . The possibility that the larger product was derived from a related gene or pseudogene was excluded, since the mutations identified in each cell line were present in both transcripts (normal and larger size). We suggest that the exon contributing to the larger transcript is generated as a result of a low level of aberrant splicing that is naturally occurring. The donor and acceptor sequences correspond well to consensus splice sequences having scores of 75 and 73, respectively (22) . This may suggest a more robust rate of splicing than implied by the steady-state level of the transcript. An alternative possibility, less efficient biologically, is that the aberrant transcript is generated at a high rate but that the RNA is unstable due to the presence of the in-frame stop codons. Although similar levels of the two mRNAs were revealed by RT-PCR of several mutant cell lines, this is not to imply an increased level of the aberrant transcript. Rather, the level of the normal length mRNA is dramatically decreased or it is rapidly degraded, so as to render the two RNA species at similar levels. This was substantiated in previous studies by northern blotting. For the two mutant cell lines that had been investigated before, the mRNA appeared undetectable (17) . The prominence of the two species by RT-PCR is a reflection of the sensitivity of the procedure. We made use of a 32 cycle PCR to maximize the level of amplification without severely affecting the ratio between the two species. PCRs in the linear range of 20 cycles were done but the PCC α mRNA was not abundant enough to allow comparison between cell lines (data not shown).
What do the four mutant cell lines have in common that they would give similar, very low levels of the normal and aberrant mRNA species? All four patient cell lines share severely deleterious mutations which are consistent with rendering mRNA unstable and rapidly degraded. Cell line 117 has a mutation causing a splice defect (1671IVS+5G→C) generating a frameshift and a non-expressed second allele; cell line 503 has a frameshift (700del5) on one allele and a nonsense mutation (R288X) on the other; cell line 3148 appears homozygous for the same nonsense mutation (R288X); cell line 3153 is homozygous for another frameshift mutation (1115del4). These results, taken together, suggest that the 84 bp insertion is not associated with a mutation causing its retention in mRNA but that its prominence in the RT-PCR product in the four pccA cell lines is likely a consequence of destabilization of the normal length mRNA to a level comparable with that of the 84 bp insertion-containing sequence. RT-PCR of segment IIIA can therefore be used as a rapid indication of the mRNA status in pccA patients by simply comparing the relative levels of the two products, as shown in Figure 1 .
All four patient cell lines also share a common deletion in the mRNA, the 103 bp deletion from nt 1569 to 1671, corresponding to the skipping of an exon. In cell lines 503, 3148 and 3153, the 103 bp deletion is secondary to the mutation and it is not associated with the 84 bp insertion, i.e. no mRNA contains both the insertion and the deletion. It was also found in trace amounts compared with the other RT-PCR products. It may also be produced in normal cells, but at a level too low to be detected. However, when mRNA destabilizing mutations are present, the relative level of each species becomes more similar and favors amplification of all species, including the mRNA containing the 103 bp deletion. Unlike the foregoing, in cell line 117 the 103 bp is associated with mutation at the adjacent donor splice site. We surmise that this is the reason that it is present on the same mRNA as the 84 bp insertion.
The results presented here suggest that some genes show low levels of differentially spliced mRNAs due to the use of cryptic splice sites. Their detection would be influenced by the relative abundance of the different mRNAs produced by the gene, their relative size and by the sensitivity of the PCR assay. Similar findings have been reported for the hprt gene in Chinese hamster ovary cells, in which nonsense mutations were associated with the detection of normal trace levels of exon-deleted mRNAs (23) . The authors estimated that exon-deleted mRNAs were detectable when their levels reached ≥2% of normal length mRNA, which was decreased due to the nonsense mutations (23) . Our results agree with their findings and add frameshift mutations and splicing defects to their list of mutations that can cause mRNA destabilization and detection of rare mRNA transcripts.
These types of mutations augur caution in the interpretation of unusual splice forms of mRNA during mutation screening by RT-PCR. Just as the 103 bp deletion was present in one patient due to a causative mutation, it was also present in others as an apparently cryptic product probably present in normal cells as well. Such findings could lead to a frustrating search for mutations. At minimum, specific testing for the presence of cryptic transcripts should be made in normal cell lines as part of the mutation screening protocol when RNA-based methods are used. There are several reports of aberrantly spliced mRNA transcripts associated with nonsense or frameshift mutations (24) (25) (26) (27) . If these genes also have trace levels of the cryptic mRNAs in normal cells, it would imply that there might not be any association between the nonsense mutations and the aberrant mRNAs, even though some cases of nonsense mutations causing splicing defects have been well documented (28) . It is possible that misspliced mRNAs may constitute a 'background noise' of the cellular transcription and splicing machineries that can be revealed in patients with mRNA destabilizing mutations.
MATERIALS AND METHODS

Materials
Taq DNA polymerase was purchased from Gibco BRL. [α- 35 S]dATP (12.5 mCi/mmol) was purchased from Dupont. The T/A cloning kit used for subcloning PCR products was from InVitrogen. Plasmid sequencing was performed using the Sequenase kit (US Biochemical). All other reagents were purchased from Gibco BRL or Fisher Scientific.
Cell lines and complementation analysis
Fibroblast cell lines were obtained from patients diagnosed with propionic acidemia. Fibroblasts from patient 3148 (B.V.) were kindly provided by R. McInnes and J.T.R. Clarke and fibroblasts from patient 3153 (M.Y.) were kindly provided by J.-M. Saudubray. Their mutations were assigned to the PCCA gene by complementation analysis, which placed them in the pccA complementation group (4) . Previously reported studies are summarized in Table 2 .
Mutation analysis
Total RNA was isolated by standard techniques (29) from fibroblasts grown in α-MEM medium containing antibiotics/ antimycotics and 10% fetal calf serum. Reverse transcription and PCR amplification of the cDNA were performed as previously described (30) . PCR buffers for SSCP analysis were the same as in Dupuis et al. (31) . The PCR conditions were adapted for each set of primers. RT-PCR products were digested in order to enhance SSCP sensitivity as in Dupuis et al. (31) . The PCCA cDNA was divided into six overlapping fragments ( Table 1 ). The corrected sequence published by Stankovics and Ledley (32) was used since we have verified that our original cDNA clones correspond to this revised sequence. When a mobility shift was detected on the SSCP gel, the fragment was re-amplified using the primers used for SSCP and directly sequenced (33) . Some samples were sequenced by the core facility of the Canadian Genetic Diseases Network.
Mutations were confirmed at the genomic DNA level by
Inverse PCR
In order to carry out the genomic diagnostic on some cell lines or to identify mutations causing splicing defects, we determined the sequence of neighboring introns and their splice donor-acceptor sites. To achieve this, we used inverse PCR (34) and normal PCR to obtain upstream or downstream sequence. The PCR products were subcloned using the TA cloning kit (InVitrogen) and sequenced.
